Natural Alternatives net loss widens 52% to $20.7 million in fiscal 2026; net sales rise 10% to $142.52 million
NAII•Natural Alternatives International reported a fiscal 2026 net loss of $20.7 million, up 52%, while net sales rose 10% to $142.52 million. Management expects a net loss in fiscal 2027 and flagged substantial doubt about the company’s ability to continue as a going concern tied to covenant compliance risk.
1. Fiscal 2026 results
Natural Alternatives International’s loss from operations widened to $18.75 million, including a $10.41 million non-cash impairment loss. Private-label contract manufacturing sales rose 11% to $134.62 million, while patent and trademark licensing sales were $7.9 million. Net cash used in operating activities was $8.9 million, and cash, cash equivalents and restricted cash totaled $7.5 million on June 30, 2026.
